Literature DB >> 25736868

Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration.

Toshihiko Mikami1, Satoshi Maruyama, Tatsuya Abé, Takanori Kobayashi, Manabu Yamazaki, Akinori Funayama, Susumu Shingaki, Tadaharu Kobayashi, Cheng Jun, Takashi Saku.   

Abstract

Expression of keratin (K) 13 is replaced with that of K17 when squamous cells of the oral mucosa transform from normal and dysplastic epithelia to carcinoma in situ (CIS) and squamous cell carcinoma (SCC). Since 14-3-3 sigma is functionally associated with K17, we examined possible relationships between expression of K17 and 14-3-3 sigma in oral CIS and SCC tissues by immunohistochemistry. We furthermore examined whether or not K17 expression or knockdown by small interfering RNA (siRNA) modulates the behavior of SCC cells in culture in terms of cell proliferation and migration. In tissue specimens of oral SCC and CIS, the pattern of cytoplasmic expression of 14-3-3 sigma and K17 was similar but neither was expressed in normal or dysplastic epithelia. Both proteins were demonstrated in the cytoplasm of control oral SCC ZK-1 cells, but expression of 14-3-3 sigma changed from cytoplasmic to nuclear upon knockdown of K17. In carcinoma cells, therefore, cytoplasmic localization of 14-3-3 sigma seems to accompany expression of K17. In K17-knockdown cells, proliferation was significantly suppressed at 4 days after seeding. In addition, the cell size of K17-knockdown cells was significantly smaller than that of control cells; as a result of which in the migration experiments, we found delayed closure of scratch wounds but migration as such was not affected. We conclude that K17 expression promotes SCC cell growth and cell size but does not affect cell migration. K17 expression is accompanied by cytoplasmic expression of 14-3-3 sigma, indicative of their functional relationship.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736868     DOI: 10.1007/s00428-015-1735-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  46 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Metastasis-associated genes in oral squamous cell carcinoma and salivary adenoid cystic carcinoma: a differential DNA chip analysis between metastatic and nonmetastatic cell systems.

Authors:  Satoshi Maruyama; Jun Cheng; Manabu Yamazaki; Xiao-jian Zhou; Zhi-yuan Zhang; Rong-gen He; Takashi Saku
Journal:  Cancer Genet Cytogenet       Date:  2010-01-01

3.  Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.

Authors:  Akinori Funayama; Jun Cheng; Satoshi Maruyama; Manabu Yamazaki; Takanori Kobayashi; Mei Syafriadi; Sukalyan Kundu; Susumu Shingaki; Chikara Saito; Takashi Saku
Journal:  Pathobiology       Date:  2011-05-26       Impact factor: 4.342

4.  Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells.

Authors:  Mei Syafriadi; Jun Cheng; Kai Yu Jen; Hiroko Ida-Yonemochi; Makoto Suzuki; Takashi Saku
Journal:  J Oral Pathol Med       Date:  2005-03       Impact factor: 4.253

5.  Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.

Authors:  M H Lyda; L M Weiss
Journal:  Hum Pathol       Date:  2000-08       Impact factor: 3.466

6.  Cooperative effects of genes controlling the G(2)/M checkpoint.

Authors:  T A Chan; P M Hwang; H Hermeking; K W Kinzler; B Vogelstein
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

7.  Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models.

Authors:  Ansgar Santel; Manuela Aleku; Nadine Röder; Kristin Möpert; Birgit Durieux; Oliver Janke; Oliver Keil; Jens Endruschat; Sibylle Dames; Christian Lange; Mona Eisermann; Kathrin Löffler; Melanie Fechtner; Gerald Fisch; Christiane Vank; Ute Schaeper; Klaus Giese; Jörg Kaufmann
Journal:  Clin Cancer Res       Date:  2010-11-09       Impact factor: 12.531

8.  14-3-3 sigma positively regulates p53 and suppresses tumor growth.

Authors:  Heng-Yin Yang; Yu-Ye Wen; Chih-Hsin Chen; Guillermina Lozano; Mong-Hong Lee
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

10.  Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium.

Authors:  Terué Ikarashi; Hiroko Ida-Yonemochi; Kazufumi Ohshiro; Jun Cheng; Takashi Saku
Journal:  J Oral Pathol Med       Date:  2004-02       Impact factor: 4.253

View more
  16 in total

1.  GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.

Authors:  Yurie Mikami; Shinsuke Fujii; Kengo Nagata; Hiroko Wada; Kana Hasegawa; Misaki Abe; Reiko U Yoshimoto; Shintaro Kawano; Seiji Nakamura; Tamotsu Kiyoshima
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-24       Impact factor: 4.553

2.  Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer.

Authors:  Olivia McGinn; Duncan Riley; Jessica Finlay-Schultz; Kiran V Paul; Peter Kabos; Carol A Sartorius
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

3.  A novel lncRNA derived from an ultraconserved region: lnc-uc.147, a potential biomarker in luminal A breast cancer.

Authors:  Erika Pereira Zambalde; Recep Bayraktar; Tayana Schultz Jucoski; Cristina Ivan; Ana Carolina Rodrigues; Carolina Mathias; Erik Knutsen; Rubens Silveira de Lima; Daniela Fiori Gradia; Enilze Maria de Souza Fonseca Ribeiro; Samir Hannash; George Adrian Calin; Jaqueline Carvalhode Oliveira
Journal:  RNA Biol       Date:  2021-08-13       Impact factor: 4.766

4.  Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma.

Authors:  Itsuhiro Kudo; Mariko Esumi; Yoshiaki Kusumi; Tohru Furusaka; Takeshi Oshima
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

5.  Cytokeratin 5 alters β-catenin dynamics in breast cancer cells.

Authors:  Olivia McGinn; Ashley V Ward; Lynsey M Fettig; Duncan Riley; Joshua Ivie; Kiran V Paul; Peter Kabos; Jessica Finlay-Schultz; Carol A Sartorius
Journal:  Oncogene       Date:  2020-01-27       Impact factor: 9.867

6.  Canine Gastric Carcinomas: A Histopathological and Immunohistochemical Study and Similarities with the Human Counterpart.

Authors:  Alexandros Hardas; Alejandro Suárez-Bonnet; Sam Beck; William E Becker; Gustavo A Ramírez; Simon L Priestnall
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

7.  Keratin 17 Is Induced in Oral Cancer and Facilitates Tumor Growth.

Authors:  Rumana Khanom; Chi Thi Kim Nguyen; Kou Kayamori; Xin Zhao; Keiichi Morita; Yoshio Miki; Ken-Ichi Katsube; Akira Yamaguchi; Kei Sakamoto
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis.

Authors:  Zhao Wang; Mai-Qing Yang; Lei Lei; Liang-Ru Fei; Yi-Wen Zheng; Wen-Jing Huang; Zhi-Han Li; Chen-Chen Liu; Hong-Tao Xu
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989

9.  CD163+ macrophages infiltration correlates with the immunosuppressive cytokine interleukin 10 expression in tongue leukoplakia.

Authors:  Manabu Shigeoka; Yu-Ichiro Koma; Mari Nishio; Takahide Komori; Hiroshi Yokozaki
Journal:  Clin Exp Dent Res       Date:  2019-08-01

10.  Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic cancer cells.

Authors:  Peng Chen; Zhengchao Shen; Xiaosan Fang; Guannan Wang; Xiaoming Wang; Jun Wang; Shihang Xi
Journal:  Oncol Lett       Date:  2020-03-20       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.